BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17158207)

  • 41. Protein phosphatase 1 regulatory subunit 12A and catalytic subunit δ, new members in the phosphatidylinositide 3 kinase insulin-signaling pathway.
    Geetha T; Langlais P; Caruso M; Yi Z
    J Endocrinol; 2012 Sep; 214(3):437-43. PubMed ID: 22728334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Muscle adaptation to short-term fasting in healthy lean humans.
    Soeters MR; Sauerwein HP; Dubbelhuis PF; Groener JE; Ackermans MT; Fliers E; Aerts JM; Serlie MJ
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2900-3. PubMed ID: 18397976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. L-Arginine enhances glucose and lipid metabolism in rat L6 myotubes via the NO/ c-GMP pathway.
    de Castro Barbosa T; Jiang LQ; Zierath JR; Nunes MT
    Metabolism; 2013 Jan; 62(1):79-89. PubMed ID: 22889511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway.
    Li G; Barrett EJ; Barrett MO; Cao W; Liu Z
    Endocrinology; 2007 Jul; 148(7):3356-63. PubMed ID: 17446186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Downregulation of lipin-1 induces insulin resistance by increasing intracellular ceramide accumulation in C2C12 myotubes.
    Huang S; Huang S; Wang X; Zhang Q; Liu J; Leng Y
    Int J Biol Sci; 2017; 13(1):1-12. PubMed ID: 28123341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ceramide- and oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells.
    JeBailey L; Wanono O; Niu W; Roessler J; Rudich A; Klip A
    Diabetes; 2007 Feb; 56(2):394-403. PubMed ID: 17259384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Muscle-specific deletion of the Glut4 glucose transporter alters multiple regulatory steps in glycogen metabolism.
    Kim YB; Peroni OD; Aschenbach WG; Minokoshi Y; Kotani K; Zisman A; Kahn CR; Goodyear LJ; Kahn BB
    Mol Cell Biol; 2005 Nov; 25(21):9713-23. PubMed ID: 16227617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of Akt2 in contraction-stimulated cell signaling and glucose uptake in skeletal muscle.
    Sakamoto K; Arnolds DE; Fujii N; Kramer HF; Hirshman MF; Goodyear LJ
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1031-7. PubMed ID: 16803855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. c-Jun is a downstream target for ceramide-activated protein phosphatase in A431 cells.
    Reyes JG; Robayna IG; Delgado PS; González IH; Aguiar JQ; Rosas FE; Fanjul LF; Galarreta CM
    J Biol Chem; 1996 Aug; 271(35):21375-80. PubMed ID: 8702918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids.
    Chavez JA; Knotts TA; Wang LP; Li G; Dobrowsky RT; Florant GL; Summers SA
    J Biol Chem; 2003 Mar; 278(12):10297-303. PubMed ID: 12525490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide.
    Strle K; Broussard SR; McCusker RH; Shen WH; Johnson RW; Freund GG; Dantzer R; Kelley KW
    Endocrinology; 2004 Oct; 145(10):4592-602. PubMed ID: 15256490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioactives of Artemisia dracunculus L. mitigate the role of ceramides in attenuating insulin signaling in rat skeletal muscle cells.
    Obanda DN; Hernandez A; Ribnicky D; Yu Y; Zhang XH; Wang ZQ; Cefalu WT
    Diabetes; 2012 Mar; 61(3):597-605. PubMed ID: 22315320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SRp30a (ASF/SF2) regulates the alternative splicing of caspase-9 pre-mRNA and is required for ceramide-responsiveness.
    Massiello A; Chalfant CE
    J Lipid Res; 2006 May; 47(5):892-7. PubMed ID: 16505493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intramyocellular Ceramides: Subcellular Concentrations and Fractional De Novo Synthesis in Postabsorptive Humans.
    Chung JO; Koutsari C; Blachnio-Zabielska AU; Hames KC; Jensen MD
    Diabetes; 2017 Aug; 66(8):2082-2091. PubMed ID: 28483801
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphorylation of the skeletal muscle glycogen-targetting subunit of protein phosphatase 1 in response to adrenaline in vivo.
    Walker KS; Watt PW; Cohen P
    FEBS Lett; 2000 Jan; 466(1):121-4. PubMed ID: 10648825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ceramide inhibits protein kinase B/Akt by promoting dephosphorylation of serine 473.
    Schubert KM; Scheid MP; Duronio V
    J Biol Chem; 2000 May; 275(18):13330-5. PubMed ID: 10788440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption.
    Ussher JR; Koves TR; Cadete VJ; Zhang L; Jaswal JS; Swyrd SJ; Lopaschuk DG; Proctor SD; Keung W; Muoio DM; Lopaschuk GD
    Diabetes; 2010 Oct; 59(10):2453-64. PubMed ID: 20522596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients.
    Bjørbaek C; Vik TA; Echwald SM; Yang PY; Vestergaard H; Wang JP; Webb GC; Richmond K; Hansen T; Erikson RL
    Diabetes; 1995 Jan; 44(1):90-7. PubMed ID: 7813820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutational analysis of the coding regions of the genes encoding protein kinase B-alpha and -beta, phosphoinositide-dependent protein kinase-1, phosphatase targeting to glycogen, protein phosphatase inhibitor-1, and glycogenin: lessons from a search for genetic variability of the insulin-stimulated glycogen synthesis pathway of skeletal muscle in NIDDM patients.
    Hansen L; Fjordvang H; Rasmussen SK; Vestergaard H; Echwald SM; Hansen T; Alessi D; Shenolikar S; Saltiel AR; Barbetti F; Pedersen O
    Diabetes; 1999 Feb; 48(2):403-7. PubMed ID: 10334321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protein kinase C-induced activation of a ceramide/protein phosphatase 1 pathway leading to dephosphorylation of p38 MAPK.
    Kitatani K; Idkowiak-Baldys J; Bielawski J; Taha TA; Jenkins RW; Senkal CE; Ogretmen B; Obeid LM; Hannun YA
    J Biol Chem; 2006 Dec; 281(48):36793-802. PubMed ID: 17030510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.